⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 2, 2022International Journal of Molecular SciencesOpen Access

PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA

View Full Paper

Ask AI

Bookmark

Share

Abstract

Sc]Sc-NODAGA-AMBA to GRPR outlines its potential to be a valuable radiotracer in the imaging of GRPR-positive PCa.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kálmán-Szabó et al. (2022) studied this question.

synapsesocial.com/papers/6a02548ddc09a3db38b364ad https://doi.org/10.3390/ijms231710061

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Preclinical Evaluation of Novel 64Cu-Labeled Gastrin-Releasing Peptide Receptor Bioconjugates for PET Imaging of Prostate CancerIn Vitro Study · 2021 · 10 citations
2Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid–Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic RadionuclidesOriginal Research · 2009 · 177 citations
3Regulation and signaling of human bombesin receptors and their biological effectsReview · 2009 · 78 citations
4PET of Somatostatin Receptor–Positive Tumors Using <sup>64</sup>Cu- and <sup>68</sup>Ga-Somatostatin Antagonists: The Chelate Makes the DifferenceIn Vitro Study · 2011 · 263 citations
5Matching the Decay Half-Life with the Biological Half-Life: ImmunoPET Imaging with <sup>44</sup>Sc-Labeled Cetuximab Fab FragmentOriginal Research · 2014 · 91 citations